Hematopathology, 3rd Edition by Elaine Sarkin Jaffe - ISBN: 9780323831659
Hardcover
Essential hematopathology: Accurate diagnoses, latest classifications, improved patient outcomes.
Save 4%
RRP$538.94

$519.98

  • Hardcover

    1312 pages

  • Release Date

    4 September 2024

Check Delivery Options

Summary

Selected for 2025 Doody’s Core Titles® with “Essential Purchase” designation in Surgical Pathology

Covering the broad range of benign and malignant disorders that affect the hematopoietic system, Hematopathology, 3rd Edition, remains your #1 source of authoritative information in this fast-changing field. Edited by Dr. Elaine Jaffe and a team of globally renowned, expert co-editors, it offers a wealth of up-to-date information in an easily accessible format, …

Book Details

ISBN-13:9780323831659
ISBN-10:0323831656
Author:Elaine Sarkin Jaffe, Daniel A. Arber, Elias Campo, Leticia Quintanilla-Fend, Attilio Orazi, Lisa M. Rimsza, Steven H. Swerdlow
Publisher:Elsevier - Health Sciences Division
Imprint:Elsevier - Health Sciences Division
Format:Hardcover
Number of Pages:1312
Edition:3rd
Release Date:4 September 2024
Weight:3.90kg
Dimensions:216mm x 276mm
A-Format
B-Format
C-Format
Hematopathology, 3rd Edition by Elaine Sarkin Jaffe - ISBN: 9780323831659
216 × 276 mm
A4
mm / in
What They're Saying

Critics Review

“This book remains one of the must-haves for anyone signing out hematopathology specimens. It is comprehensive and appropriate for all levels of expertise, and it is a great learning resource for hematopathology fellows.” ©Doody’s Review Service, 2025, Anamarija Perry, MD (University of Michigan Medical School), Doody’s Score: 99 - 5 Stars!

About The Author

Elaine Sarkin Jaffe

Dr. Elaine Jaffe is regarded by her peers as one of the most pre-eminent hematopathologists of her generation. She is most widely known for her work regarding the pathophysiology and prognosis of malignant lymphomas, as well as her unparalleled work to understand how they respond to treatment. Dr. Jaffe led the effort to develop the World Health Organization classification of tumors of the hematopoietic and lymphoid tissues published in 2001, a classification that rapidly became the international standard.

Dr. Daniel Arber is an internationally recognized expert in the diagnosis and classification of hematopoietic tumors, including malignant lymphoma, acute and chronic leukemia, myeloproliferative disorders, myelodysplastic syndrome and tumors of the spleen. He is the clinical director of the Biomedical Diagnostic Centre of Hospital Clinic and a full Professor of Anatomical Pathology at the University of Barcelona, where he also teaches in the Department of Anatomical Pathology, Pharmacy and Microbiology. He is the Spanish coordinator of the International Cancer Genome Consortium.

Professor Dr. Leticia Quintanilla de Fend, head of the Core Facility and Senior Physician at the Institute of Pathology has extensive experience in the interpretation of mouse models. From 2000 until 2008 she was a director of the mouse pathology at the Institute of Pathology of the Helmholtz Center Munich and the Pathology Screen of the German Mouse Clinic (GMC) and established various special procedures for the analysis of mouse models. Professor Quintanilla de Fend is involved in the establishment of standards in the pathology of mouse models within EU networks.

Dr. Attilio Orazi is an internationally renowned academic hematopathologist whose diagnostic expertise spans all areas of hematopathology. However, he is best known for his expertise and scholarly accomplishments as a bone marrow pathologist. He is a member of the Scientific Committee of the European Bone Marrow Working Group, has directed courses concerning the assessment of bone marrow disorders and splenic pathology at the United States and Canadian Academy of Pathology and was the co-organizer of the 2007 Workshop of the Society of Hematopathology.

Returns

This item is eligible for free returns within 30 days of delivery. See our returns policy for further details.